Second Targeted Therapeutic Approved for Use Based on Tumor Biomarker, Not Tumor Origin
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a new wave of molecularly targeted...
Category: Featured
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a new wave of molecularly targeted...
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
This spring, in the inaugural year of the American Association for Cancer Research (AACR) Global-Scholar-In-Training Awards (GSITA) program, 15...
Every two minutes, a woman somewhere in the world dies of cervical cancer. That harrowing statistic, shared by Anna R....
Every person who hears the words “you have cancer” has a unique story. As part of Cancer Today’s mission...
When I started my postdoc at Georgetown University’s Lombardi Comprehensive Cancer Center in May 2016, I was thrilled to...
Decades of research have led to the identification of an increasing number of cancer-causing substances in our environment. These...
In the past year, the number of American teenagers using tobacco products has increased by nearly 40 percent, reversing...
The tobacco product landscape is evolving and the AACR Tobacco Products and Cancer Subcommittee has been cognizant of the...
On Saturday, May 4, Philadelphians flooded the Benjamin Franklin Parkway for the Franklin Institute’s ninth annual Philadelphia Science Festival....